Characteristics of congenital hepatic fibrosis in a large cohort of patients with autosomal recessive polycystic kidney disease.
about
Drug Induced Liver Injury: Review with a Focus on Genetic Factors, Tissue Diagnosis, and Treatment OptionsPathophysiology of childhood polycystic kidney diseases: new insights into disease-specific therapyTelmisartan ameliorates fibrocystic liver disease in an orthologous rat model of human autosomal recessive polycystic kidney diseaseWhole exome sequencing identifies recessive PKHD1 mutations in a Chinese twin family with Caroli diseaseChanges in liver and spleen volumes after living liver donation: a report from the Adult-to-Adult Living Donor Liver Transplantation Cohort Study (A2ALL)Kidney and liver transplantation in children with fibrocystic liver-kidney disease: data from the US Scientific Registry of Transplant Recipients: 1990-2010.Factors associated with the platelet count in patients with chronic hepatitis C.Diagnosis and Management of Hepatobiliary Complications in Autosomal Recessive Polycystic Kidney DiseaseAutosomal recessive polycystic kidney disease: a hepatorenal fibrocystic disorder with pleiotropic effectsConsensus expert recommendations for the diagnosis and management of autosomal recessive polycystic kidney disease: report of an international conference.Rationale, design and objectives of ARegPKD, a European ARPKD registry studyMagnetic resonance microscopy of renal and biliary abnormalities in excised tissues from a mouse model of autosomal recessive polycystic kidney diseaseGrowth in Children with Autosomal Recessive Polycystic Kidney Disease in the CKiD Cohort StudyPediatric living donor liver transplantation for congenital hepatic fibrosis using a mother's graft with von Meyenburg complex: A case report.Balancing and communicating the risks and benefits of biologics in pediatric inflammatory bowel diseaseClinical manifestations of autosomal recessive polycystic kidney disease (ARPKD): kidney-related and non-kidney-related phenotypes.Clinical implications of ageing for the management of IBD.Transplantation in autosomal recessive polycystic kidney disease: liver and/or kidney?Tumor necrosis factor-alpha antagonists twenty years later: what do Cochrane reviews tell us?Tesevatinib ameliorates progression of polycystic kidney disease in rodent models of autosomal recessive polycystic kidney disease.Emerging Therapies for Childhood Polycystic Kidney Disease.Long-term pulmonary function in children with recessive polycystic kidney disease.Combined and sequential liver-kidney transplantation in children.Characteristics of Liver Disease in 100 Individuals With Joubert Syndrome Prospectively Evaluated At A Single Center.Compound heterozygous PKHD1 variants cause a wide spectrum of ductal plate malformations.Severe Polycystic Liver Disease Is Not Caused by Large Deletions of the PRKCSH Gene.Congenital abnormalities and hepatoblastoma: a report from the Children's Oncology Group (COG) and the Utah Population Database (UPDB).Congenital hepatic fibrosis in a 9-year-old female patient - a case reportClinical characteristics and mutation analysis of three Chinese children with autosomal recessive polycystic kidney disease
P2860
Q26781892-C6305B9F-6E9B-409C-A5FB-3672347F5CA1Q27000075-F07B233C-03EB-4669-8117-98CDAEC78198Q28536366-570FB24E-B153-47F8-9CB1-2318F5192A07Q28542021-76D83E16-B579-4F57-BFE7-80F25163EEE1Q30361159-03AABF4A-C4FB-4141-95A3-DC9547CCEF29Q30839484-B65ED611-B92B-4BFE-9F58-C384479774AEQ33420784-4130F8D6-D4C9-43B9-8A06-25CC25CC37C1Q33442690-ADA7A4CE-E52D-423E-8CC5-73F99BA0FE41Q34086721-BA81056B-FE7E-4F82-8300-4068480B3066Q34428848-68CA94C6-0399-449D-BAE1-1F536DD5296EQ35176977-917896E6-3F38-4A7C-A1C2-E5CD7095F365Q35759778-D9C7F3ED-52D4-4BBD-91AE-B34F275199D0Q37163122-96DB786A-E84C-4182-98B1-DE07D2D90F07Q37444299-A1061AEE-5413-4B27-98F5-F07A5D11F9FDQ37609746-725DB383-F3E0-44EC-B8C7-61F029460788Q38151554-D645F148-A4C2-4F19-9A91-A167EA3DF291Q38171926-48C1F543-D95A-4A9F-B4DC-36895DB9783EQ38239257-89809F76-08F5-4C32-AEC9-C6152FE7A341Q38258440-C40D8845-C917-4FF1-9878-E970E3C75AEAQ38668934-9DB7C566-6DF1-4055-BB71-E343E421486FQ39285003-F9F7BFC5-4CA1-4727-8297-B54B3027032BQ41114047-9E63BB5F-0CDC-4775-BA68-876F97DB72C6Q47565573-75477593-AB69-4FCC-B6D0-FCB7731A4D27Q47981846-415F5D10-024C-48CF-9EC1-F950F2B0BEA6Q53339830-36E09380-8FC8-4BBD-B68A-CA94FAD9BF51Q55043077-BE7A7688-523A-4B2C-8CC4-A725A314B979Q55717435-E29BF75F-355F-4348-B857-59F9B95469A5Q57126355-E335948A-772D-4039-B37F-748BE65175D8Q57151066-28F4EB97-F00C-452C-8CF8-F24BC15627AC
P2860
Characteristics of congenital hepatic fibrosis in a large cohort of patients with autosomal recessive polycystic kidney disease.
description
2012 nî lūn-bûn
@nan
2012 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Characteristics of congenital ...... ive polycystic kidney disease.
@ast
Characteristics of congenital ...... ive polycystic kidney disease.
@en
Characteristics of congenital ...... ive polycystic kidney disease.
@nl
type
label
Characteristics of congenital ...... ive polycystic kidney disease.
@ast
Characteristics of congenital ...... ive polycystic kidney disease.
@en
Characteristics of congenital ...... ive polycystic kidney disease.
@nl
prefLabel
Characteristics of congenital ...... ive polycystic kidney disease.
@ast
Characteristics of congenital ...... ive polycystic kidney disease.
@en
Characteristics of congenital ...... ive polycystic kidney disease.
@nl
P2093
P2860
P1433
P1476
Characteristics of congenital ...... ive polycystic kidney disease.
@en
P2093
Annelys Roque
Baris Turkbey
Daniel C Douek
Esperanza Font-Montgomery
Isa Bernardini
Jennifer Graf
Joy C Bryant
Kailash T Daryanani
Katie Piwnica-Worms
Linda Lukose
P2860
P304
112-121.e2
P356
10.1053/J.GASTRO.2012.09.056
P407
P577
2012-10-03T00:00:00Z